BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20061549)

  • 1. Antioxidant treatment attenuates pulmonary arterial hypertension-induced heart failure.
    Redout EM; van der Toorn A; Zuidwijk MJ; van de Kolk CW; van Echteld CJ; Musters RJ; van Hardeveld C; Paulus WJ; Simonides WS
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1038-47. PubMed ID: 20061549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
    Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
    Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
    Conzatti A; Colombo R; Siqueira R; Campos-Carraro C; Turck P; Luz de Castro A; Belló-Klein A; Sander da Rosa Araujo A
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):612-620. PubMed ID: 38547510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
    Wang YD; Li YD; Ding XY; Wu XP; Li C; Guo DC; Shi YP; Lu XZ
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):441-450. PubMed ID: 30350115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copaiba Oil Attenuates Right Ventricular Remodeling by Decreasing Myocardial Apoptotic Signaling in Monocrotaline-Induced Rats.
    Campos-Carraro C; Turck P; de Lima-Seolin BG; Tavares AMV; Dos Santos Lacerda D; Corssac GB; Teixeira RB; Hickmann A; Llesuy S; da Rosa Araujo AS; Belló-Klein A
    J Cardiovasc Pharmacol; 2018 Nov; 72(5):214-221. PubMed ID: 30212415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
    Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
    Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat.
    Hessel MH; Steendijk P; den Adel B; Schutte CI; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2424-30. PubMed ID: 16731643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
    Okada M; Harada T; Kikuzuki R; Yamawaki H; Hara Y
    J Pharmacol Sci; 2009 Oct; 111(2):193-200. PubMed ID: 19809219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct right ventricle remodeling in response to pressure overload in the rat.
    Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H85-95. PubMed ID: 27199115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin as a preventive and curative therapy against pulmonary hypertension.
    Maarman G; Blackhurst D; Thienemann F; Blauwet L; Butrous G; Davies N; Sliwa K; Lecour S
    J Pineal Res; 2015 Oct; 59(3):343-53. PubMed ID: 26201290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.
    Benoist D; Stones R; Drinkhill M; Bernus O; White E
    Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H2230-7. PubMed ID: 21398591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary running counteracts right ventricular adverse remodeling and myocyte contraction impairment in pulmonary arterial hypertension model.
    Soares LL; Drummond FR; Rezende LMT; Lopes Dantas Costa AJ; Leal TF; Fidelis MR; Neves MM; Prímola-Gomes TN; Carneiro-Junior MA; Carlo Reis EC; Natali AJ
    Life Sci; 2019 Dec; 238():116974. PubMed ID: 31639399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.